All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Occult HBV Infection-24302857

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	24302857	C136R	RT	P	Occult HBV Infection	S C L	View
2	24302857	G127R	RT	P	Occult HBV Infection	S C L	View
3	24302857	G127W	RT	P	Occult HBV Infection	S C L	View
4	24302857	I91L	RT	P	Occult HBV Infection	S C L	View
5	24302857	L93P	RT	P	Occult HBV Infection	S C L	View
6	24302857	L98V	S	S	Occult HBV Infection	S C L	View
7	24302857	N118T	RT	P	Occult HBV Infection	S C L	View
8	24302857	R110G	RT	P	Occult HBV Infection	S C L	View
9	24302857	S106C	RT	P	Occult HBV Infection	S C L	View
10	24302857	S119T	RT	P	Occult HBV Infection	S C L	View
11	24302857	Y126H	RT	P	Occult HBV Infection	S C L	View
12	24302857	Y158H	RT	P	Occult HBV Infection	S C L	View
13	24302857	I1110L	S	S	Occult HBV Infection	S C L	View
14	24302857	V96A	S	S	Occult HBV Infection	S C L	View
15	24302857	Y100C	S	S	Occult HBV Infection	S C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.